Global AI thought leader and FinTech pioneer to advise SciMar ONE’s technology and business operations.
ALLENTOWN, NJ, November 18, 2021 – SciMar ONE, LLC (SciMar) welcomes Ganesh Mani, Ph.D., MBA to its Board of Advisors as technology and business advisor.
Dr. Mani is a pioneer in applications of artificial intelligence (AI) and big data across verticals such as asset management, early cancer detection, and scientific knowledge. As advisor, Dr. Mani will provide insights to help guide SciMar’s technology and business operations in support of its proprietary AI technology, the Scientific Data Engine™ (SDE).
“The world is awash with information, be it scientific or quotidian. However, the average quality of information is declining; so, new tools are needed to help navigate users towards timely, reliable extracts that are also linked to similar, related content,” says Mani. “Startups like SciMar ONE, with the right innovation, have the potential to richly contribute towards information and data-driven value in healthcare.”
Dr. Mani was an early member of the Chicago Quantitative Alliance. He serves on the advisory boards for the Journal of Financial Data Science and (Cell Press) Patterns; he is former president and current board member of the Pittsburgh chapter of TiE, a nonprofit organization devoted to entrepreneurs. He is a mentor and advisor for professional organizations including Sabudh, The Financial Data Professional Institute, and IvyCap Ventures; he has been featured on ABC Nightline and in a Barron’s cover story New Brains on the Block.
Dr. Mani earned an MBA in finance and a Ph.D. in artificial intelligence from the University of Wisconsin at Madison. He has an undergraduate degree in computer science from the Indian Institute of Technology in Bombay. He resides in Pittsburgh and enjoys hiking, skiing, traveling, and spending time with his family.
About SciMar ONE, LLC:
SciMar ONE, LLC is a New Jersey-based woman-owned company with deep roots in healthcare and technology. SciMar’s mission is to cultivate advanced technologies that operationalize disease-specific clinical data for healthcare channels to accelerate efforts that improve healthcare. SciMar’s proprietary artificial intelligence (AI)-powered drug development platform, The Scientific Data Engine™, helps pharma accelerate drug development towards commercialization. Learn more at: https://www.scimarone.com
SciMar ONE, Public Relations